Interaction between DRD2 and lead exposure on the cortical thickness of the frontal lobe in youth with attention-deficit/hyperactivity disorder
暂无分享,去创建一个
Bung-Nyun Kim | J. Kim | C. Sohn | H. Yun | Jae-Won Kim | M. Shin | Jong-Min Lee | Bongseog Kim | jae-hun Roh | J. Chae | Jong-min Lee
[1] Bung-Nyun Kim,et al. The GRIN2B and GRIN2A Gene Variants Are Associated With Continuous Performance Test Variables in ADHD , 2020, Journal of attention disorders.
[2] B. Cheung,et al. Continual Decrease in Blood Lead Level in Americans: United States National Health Nutrition and Examination Survey 1999-2014. , 2016, The American journal of medicine.
[3] J. Nigg,et al. Neuropsychological performance measures as intermediate phenotypes for attention-deficit/hyperactivity disorder: A multiple mediation analysis , 2016, Development and Psychopathology.
[4] Jianhua Fu,et al. Association between ANKK1 (rs1800497) polymorphism of DRD2 gene and attention deficit hyperactivity disorder: A meta-analysis , 2015, Neuroscience Letters.
[5] J. Cheong,et al. Association between phthalates and externalizing behaviors and cortical thickness in children with attention deficit hyperactivity disorder , 2014, Psychological Medicine.
[6] K. Mccartney,et al. Gene–environment interaction between dopamine receptor D4 7-repeat polymorphism and early maternal sensitivity predicts inattention trajectories across middle childhood , 2013, Development and Psychopathology.
[7] D. K. Marcus,et al. Lead and Attention-Deficit/Hyperactivity Disorder (ADHD) symptoms: a meta-analysis. , 2013, Clinical psychology review.
[8] Shawn J Latendresse,et al. Interaction between serotonin transporter polymorphism (5-HTTLPR) and stressful life events in adolescents' trajectories of anxious/depressed symptoms. , 2012, Developmental psychology.
[9] K. Kordas,et al. A dopamine receptor (DRD2) but not dopamine transporter (DAT1) gene polymorphism is associated with neurocognitive development of Mexican preschool children with lead exposure. , 2011, The Journal of pediatrics.
[10] George Bush,et al. Cingulate, Frontal, and Parietal Cortical Dysfunction in Attention-Deficit/Hyperactivity Disorder , 2011, Biological Psychiatry.
[11] Sarah Durston,et al. Imaging genetics in ADHD , 2010, NeuroImage.
[12] J. Schwartz,et al. Hemoglobin, Lead Exposure, and Intelligence Quotient: Effect Modification by the DRD2 Taq IA Polymorphism , 2010, Environmental health perspectives.
[13] H. Forssberg,et al. Age-related reduction in dopamine D1 receptors in the human brain: from late childhood to adulthood, a positron emission tomography study , 2010, Neuroscience.
[14] I. Waldman,et al. Candidate gene studies of ADHD: a meta-analytic review , 2009, Human Genetics.
[15] Mekibib Altaye,et al. Decreased Brain Volume in Adults with Childhood Lead Exposure , 2008, PLoS medicine.
[16] J. Nigg,et al. Low Blood Lead Levels Associated with Clinically Diagnosed Attention-Deficit/Hyperactivity Disorder and Mediated by Weak Cognitive Control , 2008, Biological Psychiatry.
[17] D. Cory-Slechta,et al. Interactive Effects of a DRD4 Polymorphism, Lead, and Sex on Executive Functions in Children , 2007, Biological Psychiatry.
[18] R. Nevin. Understanding international crime trends: the legacy of preschool lead exposure. , 2007, Environmental research.
[19] Aimin Chen,et al. Lead Exposure, IQ, and Behavior in Urban 5- to 7-Year-Olds: Does Lead Affect Behavior Only by Lowering IQ? , 2007, Pediatrics.
[20] S. Berman,et al. P300 development during adolescence: Effects of DRD2 genotype , 2006, Clinical Neurophysiology.
[21] Alan C. Evans,et al. Automated 3-D extraction and evaluation of the inner and outer cortical surfaces using a Laplacian map and partial volume effect classification , 2005, NeuroImage.
[22] J. Smoller,et al. Molecular Genetics of Attention-Deficit/Hyperactivity Disorder , 2005, Biological Psychiatry.
[23] Merja Haaparanta,et al. The A1 allele of the human D2 dopamine receptor gene is associated with increased activity of striatal L-amino acid decarboxylase in healthy subjects , 2005, Pharmacogenetics and genomics.
[24] Herbert L. Needleman,et al. Low-Level Environmental Lead Exposure and Children’s Intellectual Function: An International Pooled Analysis , 2005, Environmental health perspectives.
[25] Alan C. Evans,et al. Focal decline of cortical thickness in Alzheimer's disease identified by computational neuroanatomy. , 2004, Cerebral cortex.
[26] M. Neville,et al. Identification and characterization of ANKK1: A novel kinase gene closely linked to DRD2 on chromosome band 11q23.1 , 2004, Human mutation.
[27] Young Shin Kim,et al. The reliability and validity of Kiddie-Schedule for Affective Disorders and Schizophrenia-Present and Lifetime Version- Korean version (K-SADS-PL-K). , 2004, Yonsei medical journal.
[28] D. Louis Collins,et al. Tuning and Comparing Spatial Normalization Methods , 2003, MICCAI.
[29] B. Hekimoğlu,et al. Lead encephalopathy: CT and MR findings. , 2002, Journal of computer assisted tomography.
[30] Y. S. Kim,et al. The Reliability and Validity of Korean Parent and Teacher ADHD Rating Scale , 2002 .
[31] N. Tzourio-Mazoyer,et al. Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain , 2002, NeuroImage.
[32] Alessandro Usiello,et al. Distinct functions of the two isoforms of dopamine D2 receptors , 2000, Nature.
[33] Alan C. Evans,et al. Automated 3-D Extraction of Inner and Outer Surfaces of Cerebral Cortex from MRI , 2000, NeuroImage.
[34] M. Nöthen,et al. Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers , 1999, Molecular Psychiatry.
[35] D. Cory-Slechta,et al. Nucleus accumbens dopaminergic medication of fixed interval schedule-controlled behavior and its modulation by low-level lead exposure. , 1998, The Journal of pharmacology and experimental therapeutics.
[36] John F Rosen,et al. Low-level lead-induced neurotoxicity in children: an update on central nervous system effects , 1998, Brain Research Reviews.
[37] J O Rinne,et al. The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers , 1998, Molecular Psychiatry.
[38] D. Cory-Slechta,et al. Low-level lead exposure selectively enhances dopamine overflow in nucleus accumbens: an in vivo electrochemistry time course assessment. , 1998, Toxicology and applied pharmacology.
[39] V. S. Roth,et al. Occupational lead poisoning. , 1998, American family physician.
[40] Alan C. Evans,et al. A nonparametric method for automatic correction of intensity nonuniformity in MRI data , 1998, IEEE Transactions on Medical Imaging.
[41] N. Ryan,et al. Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.
[42] J. Wu,et al. D2 dopamine receptor polymorphism and brain regional glucose metabolism. , 1997, American journal of medical genetics.
[43] E. Richfield,et al. Preferential Vulnerability of Nucleus Accumbens Dopamine Binding Sites to Low‐Level Lead Exposure: Time Course of Effects and Interactions with Chronic Dopamine Agonist Treatments , 1996, Journal of neurochemistry.
[44] Alan C. Evans,et al. Automatic Quantification of Multiple Sclerosis Lesion Volume Using Stereotaxic Space , 1996, VBC.
[45] D. Collins,et al. Automatic 3D Intersubject Registration of MR Volumetric Data in Standardized Talairach Space , 1994, Journal of computer assisted tomography.
[46] M. Memo,et al. Effect of lead exposure on dopaminergic receptors in rat striatum and nucleus accumbens , 1986, Brain Research.
[47] C. Kellogg,et al. Neonatal lead exposure: Effects on development of behavior and striatal dopamine neurons , 1981, Pharmacology Biochemistry and Behavior.
[48] B. Harrison,et al. Functional dysconnectivity of corticostriatal circuitry and differential response to methylphenidate in youth with attention-deficit/hyperactivity disorder. , 2015, Journal of psychiatry & neuroscience : JPN.
[49] J. Buitelaar,et al. ADHD: strategies to unravel its genetic architecture. , 2005, Journal of neural transmission. Supplementum.
[50] Robert Reid,et al. Adhd Rating Scale-IV: Checklists, Norms, and Clinical Interpretation , 1998 .
[51] D. Cory-Slechta. Relationships between lead-induced learning impairments and changes in dopaminergic, cholinergic, and glutamatergic neurotransmitter system functions. , 1995, Annual review of pharmacology and toxicology.